Novavax | NVAX - Ebit

Prezzo Delle Azioni
9.36
Cambio Giornaliero
1.26 15.56%
Mensile
17.29%
Annuale
57.31%
Q2 Previsione
7.87




Ebit Cambiamento Data
Adma Biologics USD 62.75M 13.56M 2025-12
Agenus USD 14.4M 19.26M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Cassava Sciences USD -13.55M 1.69M 2025-12
Geron USD -10.79M 3.1M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
MannKind USD -69.24M 28.19M 2025-12
Merck USD -1.88B 8.12B 2026-03
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Moderna USD -1.39B 531M 2026-03
Novartis USD 4.06B 413M 2025-12
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.99B 340M 2026-03
Sanofi EUR 1.94B 239M 2026-03
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12